Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Issued (2016 - 2025)

Historic Shares Issued for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to $2.6 million.

  • Agios Pharmaceuticals' Shares Issued fell 4719.12% to $2.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.7 million, marking a year-over-year decrease of 3992.52%. This contributed to the annual value of $8.7 million for FY2025, which is 3992.52% down from last year.
  • As of Q4 2025, Agios Pharmaceuticals' Shares Issued stood at $2.6 million, which was down 4719.12% from $4.4 million recorded in Q3 2025.
  • Agios Pharmaceuticals' 5-year Shares Issued high stood at $25.7 million for Q2 2021, and its period low was $16000.0 during Q2 2022.
  • Its 5-year average for Shares Issued is $3.4 million, with a median of $1.8 million in 2023.
  • Its Shares Issued has fluctuated over the past 5 years, first soared by 145405.57% in 2021, then tumbled by 9993.77% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Shares Issued (Quarter) stood at $267000.0 in 2021, then crashed by 60.67% to $105000.0 in 2022, then skyrocketed by 706.67% to $847000.0 in 2023, then skyrocketed by 471.66% to $4.8 million in 2024, then plummeted by 47.19% to $2.6 million in 2025.
  • Its Shares Issued was $2.6 million in Q4 2025, compared to $4.4 million in Q3 2025 and $65000.0 in Q2 2025.